Is the Aconex Ltd share price cheap?

Can Aconex Ltd (ASX:ACX) outperform the market in the years ahead?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in cloud-connected construction software business Aconex Ltd (ASX: ACX) dropped 1.6 per cent to $4.89 today after the group provided an update at its 2017 AGM.

The former market darling has been on a wild ride since its 2014 IPO with shares shooting up to $8.29 in July 2016 before a profit downgrade and series of disappointing updates saw shares fall to $3.08 early in 2017.

It appears the market is finding the stock a little easier to value now with Aconex's management team forecasting revenue growth of 15%-19% in FY 2018 alongside undetermined EBITDA growth.

Over the "medium-to-long term" management maintained its revenue growth targets of 20%+, although given its track record in meeting forecasts since its IPO investors should take these loose forecasts with a pinch of salt.

In FY 2017 Aconex delivered EBITDA of $15 million on revenues of $161.2 million with the company currently ascribed a market value of close to $1 billion. This puts mid-2016's market value around $1.6 billion on 10x revenues or more than 100x EBITDA into perspective and shows how investor excitement over tech shares in the software-as-a-service space can sometime lead to excessive valuations.

On 6x trailing sales, Aconex still looks expensive using conventional SaaS business valuation metrics and today's investors will expect double-digit compound annual growth rates in the bottom line over the years ahead. However, given its mixed track record as a public company and valuation I'm not a buyer of Aconex shares.

Tomorrow, cloud accounting business XERO FPO NZ (ASX: NZX) will hand in its full year results with its stock up 80% over the past year. It's a business I like, but I wouldn't suggest considering the buying shares until being able to digest the numbers revealed in tomorrow's update.

Motley Fool contributor Tom Richardson owns shares of Xero. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of ACONEX FPO and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »